planned Benefit-level benchmarking from normalized CMS Landscape and Plan Benefit Package data is planned. Until then this hub covers Part D economics, the out-of-pocket cap, negotiated prices and modeled benefit pressure.
Where are Medicare drug economics and benefit pressures moving?
IRA out-of-pocket cap, deductible strategy, benefit-value trend.
Vintages differ by dataset on this page. Each card states the CMS source and the period its figure covers; enrollment, plan, star-rating and policy files are published on different schedules and are never forced onto one date. Every source, vintage and refresh cadence →
How is the IRA out-of-pocket cap reshaping Part D benefit design?
How far are negotiated prices below the CMS list price?
How fast is supplemental benefit value eroding?
Where is Part D drug spend growing fastest by drug and prescriber?
Drug- and prescriber-level spend growth is on the public roadmap, arriving with the Part D PUF pipeline.